Benzinga | Jul 31, 2020 06:38AM EDT

SVB Leerink Maintains Outperform on Alexion Pharmaceuticals, Raises Price Target to $163

SVB Leerink analyst Geoffrey Porges maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and raises the price target from $159 to $163.